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Abstract 
Objective: The aim of this study was to examine the potential of a novel 3-fluid nozzle 
spray drying technology to formulate differentiated layered microparticles (MPs) of 
diclofenac sodium (DFS)/Ethyl cellulose (EC).  
Methods: DFS/EC MPs were formulated using the inner and/or outer nozzles of a novel 
3-fluid nozzle and compared with MPs formed using conventional (2-fluid) spray drying. 
MPs were characterised for particle size and for morphology by TEM and SEM. 
Distribution of DFS and EC of MPs was analysed by FT-IR and DSC. A 2-factor, 3-level 
(3
2
) factorial design was applied to investigate the effect and interaction of total feed 
solid content (TSC) and feed flow rate (FFR) on MP size, D50% and D90%, bulk density 
and MP yield.  
Results: Interestingly, TEM demonstrated that MPs formed by 3-fluid nozzle spray 
drying showed a heterogeneous internal morphology consisting of a core and coat, 
characteristic of a microcapsule. In comparison, MPs from conventional spray drying 
showed a homogeneous internal morphology, characteristics of a matrix system. This 
differential distribution of DFS/EC was supported by FT-IR and DSC. Results of 
multiple linear regression analysis showed a linear relationship for the effect of TSC and 
FFR on all responses except for D50%where a quadratric model was valid. The effect of 
TSC/FFR on MP size and yield was similar to conventional spray drying.    
Conclusion: The novel 3-fluid nozzle spray drying offers a new method of designing 
layered microparticles or microcapsules which can have wide applications from drug 
stabilisation to controlled drug delivery and targeting. 
 
Keywords: Spray drying, 3-fluid nozzle, 2-fluid nozzle, factorial design, ethyl cellulose, 
diclofenac sodium 
 
 
 
 
 
Page 2 of 31
URL: http://mc.manuscriptcentral.com/eodd  Email: anneke.prins@informa.com
Expert Opinion on Drug Delivery
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
3 
 
 
1. Introduction  
Microencapsulation is a technique widely used in the pharmaceutical industry for a 
number of applications including controlled drug release, targeted drug delivery and taste 
masking [1]. Numerous microencapsulation techniques have been developed over the 
years and these range from solvent evaporation from emulsions to coacervation-phase 
separation, coating of non-pareil beads and spray drying. Microencapsulation of 
pharmaceutical actives using spray drying is a well established method and the 
formulation and process parameters influencing microencapsulation have been studied 
extensively [2-4]. The spray drying process generally consists of atomizing the feed fluid 
through a nozzle to form fine droplets which are dried in a stream of hot drying air or 
nitrogen. The dried particles are separated from the drying medium and are collected into 
a collecting vessel [5, 6].   
The atomiser/nozzle play a very important role in defining the droplet size formed hence 
the particle size and size distribution of the product and various types of nozzles, ranging 
from single fluid to 4-fluid nozzles, centrifugal wheel rotary atomizer, rotating disc 
atomizer and ultrasonic nozzle have been investigated [7-12].  
 
Of these, the 2-fluid (2-F) nozzle is the most commonly used for the formulation of 
microparticles for various applications. Considerable data have been published to date on 
the effect of process and formulation variables on the characteristics of the resultant 
microparticles [4, 13-15]. A change in the feed flow rate was reported to directly 
influence the particle size, and inversely influence the particle size distribution, particle 
morphology and product recovery [13]. Similarly, an increase in the total solid content of 
feed solutions was reported to directly impact microparticle size. Clarke et al. reports that 
for the biodegradable PLA and PLGA polymers, polymer molecular weight and 
concentration were important factors influencing microparticle formation and observed 
an increase in microparticle size with increasing polymer concentration [15]. 
In general, spray dried microparticles (MPs) or microspheres of drug and polymer tend to 
consist of a matrix structure where the drug is distributed within the polymer matrix and 
serve the purpose of protection/stabilisation or controlled release of the actives [4, 13]. 
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As the active in a microparticle matrix structure is usually distributed throughout the 
particle, it is present at the particle surface and gives rise to a fast initial or burst drug 
release. Similarly such surface exposure of drug potentially leads to degradation of labile 
molecules [14, 16]. For efficient sustained release of drug from MPs, microcapsule 
formation is reported to be desirable [17]. Similarly, microcapsules would be desirable 
for protection of labile molecules. The co-axial nozzle systems have been previously 
reported for microcapsule production by the method of electrospraying giving high yield 
and particles of uniform size distribution [18].  
A novel 3-fluid nozzle has been reported earlier by Legako et al [19] for the formulation 
of microcapsules of whey protein solution and fish oil. Application of the 3-fluid nozzle 
to the formulation of drug polymer microparticles is novel and was first described by 
Ramtoola et al [20].  
 
In this study, we examined the potential of a novel 3-fluid (3-F) nozzle spray drying to 
form 2-layered MPs or microcapsules. It is envisaged that as a result of the nozzle 
configuration, which allows the feeding of 2 separate concentric streams of the active and 
polymer solutions [20], the drug and polymer solutions will form a two layered droplet at 
the nozzle tip to give MPs with internal morphology similar to a microcapsule (Figure 
1a). In comparison, using the 2-F nozzle, the drug/polymer solution generally formulated 
as one feed solution is fed through a single feed line and sprayed through a single nozzle 
(Figure 1b) to result in a matrix type of particles.  
 
The characteristics and internal morphology of MPs formulated using the novel 3-F 
nozzle was first examined and compared with MPs formed using 2-F nozzle spray drying. 
Diclofenac sodium (DFS), a non-steroidal anti-inflammatory analgesic drug was used as 
a model drug and ethyl cellulose, an inert hydrophobic polymer, was used as the 
encapsulating polymer. A two factor, three level (3
2
) factorial design and response 
surface methodology were applied to derive statistical models to investigate the relative 
significance of two variables, total solid content of the feed solution (X1) and feed flow 
rate (X2) and their interaction on the responses i.e. median microparticle size, D50% (Y1), 
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microparticle size at which 90% of the particles are below, D90%  (Y2), bulk density (Y3) 
and microparticle yield (Y4).  
2. Materials and methods  
2.1 Materials 
Diclofenac sodium (DFS) USP grade was bought from Dipharma Francis, Italy. Ethyl 
cellulose (EC) (45cP) was bought from Sigma-Aldrich, Ireland. Ethanol (EtOH) Reagent 
grade was bought from Lennox, Ireland. 
 
2.2 Preparation of the spray-dried microparticles  
Feed solutions containing diclofenac sodium (DFS) or ethyl cellulose (EC) as two 
individual solutions were spray dried (Buchi Mini Spray dryer, Model B-290 (Buchi 
Switzerland)) using a novel 3-F nozzle. The DFS solution was fed through the inner core 
of the nozzle using a second pump (Ecoline pump, Ismatec), whereas the EC solution was 
fed through the second or outer feed layer of the 3-F nozzle. Fluidising nitrogen was fed 
through the third nozzle. The feed flow rate (FFR) of DFS and ethanolic solutions were 
maintained at the same rate and were in the range 2-8mL/min. The total solid content 
(TSC) of each feed solutions used were 2.5, 5 or 10 % w/v. The inlet temperature (Tinlet) 
was set at 80
o
C and the air (in this case nitrogen) aspiration rate was controlled at 100%. 
This nitrogen drying gas carries the spray dried microparticles to the cyclone separator 
and subsequently to the collector from where the microparticles are recovered. Flow rate 
of fluidizing nitrogen was maintained at 400 Nl/h. Outlet temperatures were monitored 
during the spray drying process. The dry product was collected and weighed and product 
yield (%) was calculated, (weight of the spray-dried product/total solids in the feed 
solution) × 100.  
MPs were also prepared by spray drying using the standard 2-F nozzle. Feed solutions in 
this case consisted of a single solution of DFS and EC in ethanol at 2.5, 5 or 10% w/v 
TSC using a feed flow rate of 2-8mL/min. The process parameters used were as 
described for the 3-F nozzle. 
 
2.3 Characterisation of spray-dried microparticles  
2.3.1 Microparticle size analysis and bulk density  
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The particle size and size distribution of the spray dried MPs was measured using the 
Mastersizer 2000 (Malvern Instruments, Malvern, Worcestershire, UK). The 
microparticles were measured for size in the dry state using the dry dispersion attachment 
(Scirocco™). Briefly, a small amount of sample was placed onto the sample tray of the 
dry powder cell and measured for D10%, D50%, D90%. 
The bulk density (g/cc) was calculated from the accurately weighed MPs (g) and the 
corresponding bulk volume (cc) measured using a graduated cylinder.  
 
2.3.2 Morphology  
External morphology of the MPs was evaluated by a variable pressure field emission 
scanning electron microscope (SEM) (Hitachi Scanning Electron Microscope (model S 
3500N, Japan). Samples were mounted on double-sided adhesive tape attached to an 
aluminium stub and were sputter coated with gold to approximately 30 nm (Polaron 
SC500, Gold Sputter Coater, Quotum Technologies, Newhaven, UK) [21]. Internal 
morphology of MPs was investigated by transmission electron microscope (TEM) 
(Hitachi- 7650 with a side mount 2k AMT camera). Dry microparticle samples were 
mounted onto Pioloform mesh copper grids with or without 2% phosphotungstic acid 
(PTA) for negative staining. The grids were observed under the TEM operated at 100kV. 
Images were taken at 7k or 10k magnifications. 
 
2.3.3 Drug loading and encapsulation efficiency  
Accurately weighed MPs (~5 mg) were dissolved in 2 ml ethanol by sonication for 30 
minutes and phosphate buffered saline at pH 6.8 was then added to precipitate the EC 
polymer. After centrifugation, 1 ml aliquot of the supernatant was diluted with 10 ml of 
pH 6.8 and the absorbance was then measured using UV Spectroscopy (Libra S22, 
Biochrom, UK) at λmax 276 nm. The drug content of the samples was then calculated 
using a standard calibration curve for DFS in the concentration range of 0.005 – 0.05 
mg/ml. “The drug assay method was verified using physical mixtures of DFS and EC and 
showed 100% drug extraction. In addition, the UV scan for EC solutions showed no 
absorbance over the 250-400nm range and hence no interference with the DFS 
absorbance at 276nm.” 
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The percent drug loading of the MPs and encapsulation efficiency (EE) of DFS in the 
MPs were calculated by: 
 % DFS loading = (amount of DFS in MPs/ weight of MPs) x 100.  
 EE = (assayed drug content per 5mg of MPs / theoretical drug content per 5mg of MPs) 
x 100. 
 
2.3.4 Fourier Transform Infra-Red spectroscopy 
Fourier Transform Infra-Red (FT-IR) spectroscopy spectra were obtained using a Bruker 
Tensor 27 FT-IR spectrometer (Bruker. Optics, Ettlingen, Germany) equipped with 
DTGS detector. The background scan was performed prior to analysis. The spectra were 
an average of 32 scans at a resolution of 4 cm
-1
 over the frequency range of 4000 – 400 
cm
-1
. KBr discs were prepared using a manually operated hydraulic press (Specac, Kent, 
UK). Analysis of the spectra was performed using the OPUS Data Collection Program (V 
1.1). The samples for infrared analysis and the KBr were dried for at least an hour prior 
to analysis in a drying oven (Specacabinet, Kent, UK) at 32 ± 0.5
o
C.  
 
2.3.5 Differential Scanning Calorimetry  
Differential scanning calorimetry (DSC) analysis was carried out on spray dried MPs 
using a DSC Q100 V9.0 Build 275, with a recirculation cooling system (TA Instruments, 
New Castle, Delaware, USA). Samples were accurately weighed and sealed in aluminum 
pans. An empty aluminum pan was used as the reference. The analysis was performed 
under a purge of dry nitrogen. Samples were heated by a ramp method at a rate of 
10°C/min over the temperature range 10-300°C and the thermograms examined for phase 
changes/ evidence of degradation. DSC was also carried out on the unprocessed DFS, EC 
and 1:1 physical mixture (PM) of the DFS and EC. The temperatures at which thermal 
events were observed were recorded. Calibration of the instrument was performed with 
indium reference standard prior to the start of the study.  
 
2.3.6 Experimental design  
Factorial design and response surface methodology was used to determine the 
significance of each independent factor studied and their interaction over the considered 
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responses. It can be used to find the best combination of a given set of factors, which give 
an optimal response [22]. In this study, it was applied to evaluate the effect of the 
independent formulation and process factors of total solid content (X1) and feed flow rate 
(X2) and their levels and interaction on the resultant microparticle size, density and 
particle yield (Y1 – Y4) and hence allow selection of optimum parameters for desirable 
MP properties. The independent variables studied, their levels and responses measured 
are shown in Table 1. 
 
The matrix of the factorial design is outlined in Table 2. Each row in the matrix 
represents an experiment and each experiment presents a set of results i.e. 4 responses or 
dependent variables studied. The selected levels are within the practical use and were 
chosen to have a measurable effect on the response. 
 
3.0 Results  
3.1 Evaluation of novel 3-fluid spray drying nozzle for microcapsule engineering  
Droplet and particle formation using the 3-F nozzle was first investigated. MPs formed 
by feeding DFS or EC solution, at 5% w/v, through inner or outer layer of the 3-F nozzle, 
respectively, at increasing feed flow rate (FFR) were compared with corresponding MPs 
formed using the 2-F nozzle (Table 3). MPs were subsequently formulated using both 
inner and outer nozzles of the 3-F nozzle simultaneously (Table 3). Spray dried MPs 
were formed in all cases. Particle yield decreased with increasing FFR. A lower yield of 
20-69% was obtained for the 3-F nozzle compared to 2-F nozzle (29-91%). Highest yield 
was obtained at the lowest FFR of 2mL/min for both nozzles (40-69%), while at higher 
FFR, particularly at 8mL/min, yield was reduced (16-33%). 
 
Increasing the FFR from 2-8mL/min did not affect median particle size of particles 
prepared using the 2-F nozzle or the inner core of the 3-F nozzle (Table 3). An increase 
in the D90% value (from 15-25 μm to 29-46 μm) was however observed at the highest 
FFR of 8mL/min for both nozzle types. Particle size of MPs prepared using the outer 
layer of the 3-F nozzle was observed to decrease (D50%, from 6.2 to 3.4 μm; D90%, 
from 14.2 to 6.9 μm) with increasing FFR (from 2 mL to 8 mL).  
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MPs from the 3-F nozzle showed a defined core and coat internal morphology, similar to 
a microcapsule (Figure 2a). This is contrast to DFS and EC MPs from the standard 2-F 
nozzle, which showed a homogeneous internal morphology, representative of a matrix 
system (Figure 2b). MPs from outer 3-F nozzle appeared hollow and collapsed (Figure 
2c). 
 
3.1.1 Fourier Transform Infra-Red (FT-IR) spectroscopy 
FT-IR analysis of DFS shows characteristics peaks at 3388 cm
-1
 and 3258 cm
-1
 
corresponding to NH stretching of its secondary amine and amide band II, respectively, 
strong -C=O peak at 1791 cm
-1
 and -C-O peak at 1247 cm
-1
. The shoulder peak at 1669 
cm
-1
 and peak at 892 cm
-1
 can be related to the aromatic ring whereas the peak at 1168 
cm
-1
 was attributed to aromatic C-Cl (Figure 3A). These were consistent with the 
literature [23-25]. These DFS peaks were observed in the 1:1 PM of DFS with EC 
(Figure 3B). The peaks relating to aromatic ring and aromatic C-Cl of DFS were clearly 
visible in MPs prepared using 2-F nozzle, interestingly, these peaks were either absent or 
subdued in MPs prepared using 3-F nozzle.  
FT-IR for EC was reported to show a small but not sharp peak at 2950 cm
-1 
attributed to 
asymmetric structure vibrations of the -OC2H5 ethoxy groups [26], and broad distinct 
peak near 1100 cm
-1 
corresponding to the C-O-C stretch in the cyclic ether [27, 28]. Both 
these events are observed in the FTIR of MPs prepared using either 2-F or 3-F nozzle, 
however these peaks were stronger in intensity in the FTIR of MPs from 3-F.  
 
To investigate the mechanism of particle formation, droplet formed through the 3-F 
nozzle was visualized at a low flow rate of ~0.5mL/min, using a rhodamine solution as 
core solution through the inner nozzle, and a clear polymer solution through the outer 
nozzle. The droplet formed at the tip of the nozzle showed a pink coloured core droplet 
within a clear outer polymer coat (Figure 4a), in contrast, the droplet formed at the tip of 
the 2-F nozzle using a rhodamine and polymer solution, was homogeneous and darker in 
colour (Figure 4b).  
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3.2 Effect of formulation and process variables on microcapsule characteristics and 
morphology  
3.2.1 Statistical analysis and mathematical modelling 
The influence of increasing total solid content (X1) of the feed solution and feed flow 
rate (X2) on the microparticle characteristics was analysed by response surface modeling 
using the Design-Expert® software. The values for the responses, Y1 = median 
microparticle size (D50%), Y2 = the size at which 90% of MPs are below (D90%), Y3 = 
bulk density, Y4 = microparticle yield are shown in Table 4. The statistical models were 
developed based on the regression analysis of statistically significant variables and the 
results for each response variable derived by the best fit method are shown in equations 
(1)-(4) below.  
 
Y1 (D50%) = +7.47639 +0.66186 * X1 -1.30925 * X2 -0.082310 * X1 * X2                       
-0.015378 * X12 +0.22704 * X22       (1) 
 
Y2 (D90%) = -0.16333 +2.17657 * X1 +2.65714 * X2    (2) 
 
Y3 (bulk density) = +0.15736 +6.09905E-003 * X1 -4.12771E-003 * X2  (3) 
 
Y4 (microparticle yield) = +88.74222 -2.51924 * X1 -5.57316 * X2  (4) 
 
Equations 1-4 demonstrate the quantitative effect of the formulation and process 
variables; total solid content (X1) and feed flow rate (X2) and their interactions on the 
responses Y1-Y4. Analysis of variance (ANOVA) for the responses showed that the 
quadratic regression model was significant and valid for the effect of TSC or FFR on 
response Y1 (p=0.0106), while linear regression model was valid for the effect of TSC or 
FFR on each of the responses Y2 (p=0.0003), Y3 (p <0.0083) and Y4 (p = 0.0063) 
(p<0.05) and hence was suitable to represent the observed MP characteristics and serve as 
a response predictor. The statistical analysis for the response surface quadratic/linear 
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model showed that the standard error of estimate for Y1 was 0.56, Y2 was 1.12, Y3 was 
4.637E-003 and Y4 was 3.40 demonstrating good fit of the model.  
A positive regression coefficient of variable X1 in equations (1) – (3) indicate that an 
increase in TSC resulted in an increase in MP size and bulk density. The regression 
coefficient of variable X2 was negative in equations (1) and (3) and positive in equation 
(2) indicating a decrease in D50% and bulk density, but an increase in D90%, with an 
increase in FFR. The negative regression coefficient for X1 and X2 in equation (4) 
indicates a decrease in MP yield with an increase in TSC or FFR.  
In equation 1, the higher order factors (X1
2
 and X2
2
) and coefficients with both factors 
(i.e. X1X2) denote a quadratic relationship and an interaction effect of both factors on 
median particle size. A positive regression coefficient for the quadratic term X2
2
 
indicates that median MP size decreased with decreasing FFR, to a minimum after which 
median MP size increased.  
 
3.2.2 Analysis of the fitted data - microparticle size; D50% (Y1), D90% (Y2), bulk 
density (Y3) and yield (Y4) 
The relationship between the dependent variables; MP size, D50% (Y1), and D90% (Y2), 
bulk density (Y3) and MP yield (Y4) and the independent variables; total solid content 
(TSC) (X1) and feed flow rate (FFR) (X2) is demonstrated on the response surface plots 
in Figure 5a-d. The plots also show the region of maxima (region in red) and minima 
(region in blue) for each of the 4 responses investigated. Quality of fit of the model for 
each response showed an R
2
 value of 0.9784, 0.9318, 0.7973 and 0.8156 for Y1, Y2, Y3 
and Y4, respectively.  
An increase in FFR to 8mL/min led to ~2-fold increase in the particle size (D50% and 
D90%) and a decrease in yield and density, regardless of the TSC (Figure 5a-d). Figure 
5a also illustrates a quadratic relationship for the effect of FFR on median MP size. An 
increase in FFR resulted in a small decrease in the median MP size from 7-9 μm to 6-7 
μm after which median MP size increased to 11-13 μm. Both the TSC and FFR effect 
were contributory resulting in highest D90% and lowest MP yield at the highest FFR and 
TSC.  
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A linear relationship for the effect of FFR and TSC was observed on bulk density (Y3) 
and product yield (Y4) (Figure 5c,d). An increase in FFR resulted in a decrease in bulk 
density while an increase in TSC resulted in an increase in bulk density. Increase in FFR 
and TSC resulted in a decrease in yield, with minimum yield at highest TSC and FFR.  
 
3.3 Comparison of microparticle characteristics: 3-fluid nozzle vs 2-fluid nozzle  
The characteristics of MPs generated using the 3-F nozzle was compared with those of 
MPs formulated using a conventional 2-F nozzle at a FFR of 8mL/min (Table 4). MP 
size were similar for both nozzle types. An increase in TSC resulted in an increase in 
both, D50% and D90% of the MPs from the 2-F nozzle, while for 3-F MPs only D90% 
increased with an increase in TSC. At lower TSC of 2.5%, MPs from 2-F nozzle was 
denser and showed higher product yield compared to the MPs from 3-F nozzle. An 
increase in TSC to 10% resulted in a decrease in bulk density and yield of 2-F MPs. 
Consequently, at higher TSC of 10%, MPs from 3-F nozzle was denser and showed 
higher product yield compared to the MPs from 2-F nozzle.  
MPs prepared using 3-F nozzle showed high encapsulation efficiency (EE) in the range 
of 101-119%, while EE of DFS in MPs using the 2-F nozzle was in the range 95.12-
99.36%.  
 
3.4 Morphology of microparticles 
External morphology of MPs prepared using the 3-F nozzle were similar across the FFR 
and TSC examined and to the morphology of MPs from the 2-F nozzle (Figure 6a-d).  
 
3.5 Differential scanning calorimetry (DSC) 
DSC studies of unprocessed DFS and spray dried DFS showed an endothermic peak at 
293°C and 289°C, respectively, indicative of its melting point (Figure 7I), consistent 
with literature reports [29,30]. Unprocessed EC showed a broad endotherm from ~37
 
to 
~112
o
C, probably due to increase in molecular mobility (Figure 7II(b)) [31, 32]. 
Similarly, spray dried EC showed a broad endotherm, however, followed by a small 
endothermic event at ~130
o
C, which could be due to the Tg of EC at around 135°C as 
reported by Rekhi et al. [33]. The events at ~ 175
o
C and ~218
o
C were related to oxidative 
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degradation of EC at elevated temperatures [25, 32]. PM of EC with DFS showed just a 
broad endotherm, similar to that observed for spray dried EC. However, at a temperature 
of above 250
o
C, a degradation event was observed, probably related to the degradation of 
DFS [34].  
Interestingly, the DSC thermogram of MPs spray dried using 3-F nozzle was different to 
those of MPs prepared using 2-F nozzle. For 3-F nozzle MPs, the broad endothermic 
event observed at ~37-110
o
C was similar to that observed for spray dried EC. This was 
followed by an endothermic peak for DFS at ~262
o
C, before degradation. The thermal 
profiles were consistent for 3-F nozzle MPs, regardless of the TSC or FFR (Figure 7III 
and IV). MPs prepared by using 2-F nozzle showed a broader endothermic event, 
between ~37-150
o
C, compared to spray dried EC. This broader event may represent 
increased solvent residuals or can be related to DFS distribution within the EC matrix 
which interferes with EC mobility. This was followed by an exothermic event at ~225
o
C, 
possibly related to the re-crystallisation of DFS, before the degradation event observed at 
above 250
o
C.  
 
3.6 Validation of the model  
Theoretical (predicted) values of responses Y1 (particle size, D50%), Y2 (particle size, 
D90%), Y3 (bulk density), Y4 (microparticle yield) for the 9 experiments were calculated 
from the response surface models; equations (1)-(4), respectively, by substituting values 
of X1 (total solid content) and X2 (feed flow rate). Good correlation between theoretical 
(predicted) values and the observed (actual) values was found for all the four responses of 
Y1 – Y4 (Table 5a and b). A batch containing 5% TSC was reformulated at the FFR of 
8:8mL/min. The particle size D50% and D90% of reformulated batch was found to be 7.13 
± 0.32 μm and 40.6 ± 24.78 μm, respectively, the bulk density was 0.1728 g/cc and 
product yield was 33.94%.       
 
4.0 Discussion  
Spray dried MPs were formed irrespective of the type of nozzle used. MPs formed using 
the 2-F nozzle were smaller than corresponding MPs formed using the inner core of the 
3-F nozzle. This was related to the different feed solutions used as the internal diameter 
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of both nozzles was similar. A single DFS/EC solution was used for the 2-F nozzle while 
only DFS solution was used for the inner 3-F nozzle and this may have resulted in 
particle agglomeration of the DFS crystals formed on spray drying. MP size from 3-F 
nozzle was larger probably resulting in product settling in the spray drying chamber, and 
hence less product being carried by the air aspiration to the cyclone separator and 
collecting vessel, resulting in lower product yield. 
Increasing the FFR from 2-8mL/min did not affect the size of MPs from the 2-F nozzle or 
inner core of the 3-F nozzle (Table 3), however a decrease in MP size with increasing 
feed flow rates was observed when using the outer layer of the 3-F nozzle. TEM showed 
these particles to be hollow (Figure 2c), hence they tend to collapse with increasing FFR 
resulting in a decrease in the MP size.  
TEM studies showed that MPs prepared from 3-F nozzle had a defined core and coat, 
similar to a microcapsule, while using the standard 2-F nozzle a homogeneous internal 
morphology was observed. FT-IR analysis showed that MPs from 3-F nozzle were 
different to MPs from 2-F nozzle. FT-IR spectrum of 3-F nozzle MPs showed EC peaks 
that were stronger in intensity compared to the 2-F MPs. This was related to the fact that 
MPs prepared using 3-F nozzle has a coat of EC. MPs from the 2-F nozzle showed a 
similar FT-IR spectrum to 1:1 PM indicating a more homogeneous distribution of DFS in 
EC matrix, synonymous to the matrix system.        
Investigation of the droplet formation from the 3-F nozzle demonstrated that an inner 
rhodamine droplet was formed within a clear polymer coat. On drying, these droplets 
result in the formation of layered MP consistent with the internal morphology of 
microcapsules.  
Examination of the effect of increasing TSC of the feed solution and FFR on the MP 
characteristics using the 3-F spray drying nozzle showed an increase in MP size and bulk 
density with an increase in TSC (Table 4, Figure 5a-c). Similarly, an increase in MP size 
with increasing TSC was observed when using a standard 2-F nozzle. This is as expected 
as an increase in feed solid concentration will give rise to an increase in feed viscosity 
resulting in larger and denser droplets and MPs [10, 15, 35]. A decrease in MP yield with 
an increase in TSC was consistent with the literature [35, 36]. Tewa-Tagne et al. prepared 
microparticles containing polymeric nanocapsules and reported that an increase in 
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Kollidon 30 from 5% to 10% w/v in the feed preparation caused a decrease in the yield 
from 63% to 59% [36].  
Similarly, an increase in FFR led to a significant increase in MP size (D90%), and a 
decrease in yield (Table 4, Figure 5b, d). Likewise, when using a 2-F nozzle and a TSC 
of 10%, larger MP size and lowest MP yield was observed at the highest FFR rate of 
10mL/min. This was consistent with the literature. An increase in FFR was reported to 
result in an increase in size of DFS/ethylcellulose MPs, and of DFS/Eudragit RS30D MPs 
[4]. Similar observations were reported for Eudragit® MPs by Esposito et al. who also 
reported a corresponding decrease in the product yield. Both authors used a conventional 
2-F nozzle spray drying [13].  
Multiple linear regression analysis indicated a linear relationship for the effect of TSC 
and FFR on all responses except for D50%where a quadratric model was valid. Analysis of 
residuals showed good validation of the model.  
A higher EE at >100% was observed for MPs formulated at high TSC for the 3-F nozzle, 
compared to the standard 2-F nozzle. This was related to the differences in viscosity of 
DFS and EC feed solutions resulting in an overall slightly lower FFR of the EC feed 
solution and hence higher DFS:EC ratio than 1:1. 
For MPs from 3-F spray drying, DSC showed separate thermal events for the crystalline 
DFS and EC molecular mobility, demonstrating a heterogeneous structure, reflecting 
DFS in core and EC as coat and this is supported by TEM and FT-IR. DSC of MPs from 
2-F spray drying showed that the DFS was molecularly dispersed throughout the EC 
matrix and was supported by the recrystallisation of DFS at ~225
o
C. In addition, TEM 
showed that these MPs had homogeneous matrix structure, while FT-IR showed 
similarity of 2-F MPs to the corresponding PM.  
These results therefore indicate that the novel 3-F nozzle results in the formation of 
microcapsules where the DFS is in the core surrounded by a coat of EC.  
 
5.0 Conclusion 
Spray drying using a novel 3-F nozzle was shown to result in MPs with differentiated 
internal morphology. The MPs from 3-F nozzle showed an inner core of crystalline drug 
coated by EC polymer, while MPs from conventional spray drying showed DFS as 
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molecularly dispersed in EC matrix. Hence, it can be concluded that the novel 3-F nozzle 
results in the formation of multilayered and multifunctional MPs. The potential for 
forming microcapsules or coated MPs is attractive for multiple applications as it offers 
efficient environmental protection of the encapsulated core for enhanced stability/taste 
masking of bitter cores/actives and greater control of drug release because the drug is not 
located at the surface. This technology also allows formation of MPs with functionalised 
coating to enhance drug delivery and targeting. In addition, the 3-F nozzle can be used to 
formulate hollow/low density microcapsules for diagnostic and inhalation applications.  
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Table 1. Variables in 3
2
 full factorial design.  
Independent variable, factor Levels used   
Low (-1) Middle (0) High (1) 
X1; Total solid content (%) 2.5 5 10 
X2; Feed flow rate (mL/min)  2:2 4:4 8:8 
Dependent variable, response     
Y1 = microparticle size (D50%) (µm)    
Y2 = microparticle size (D90%) (µm)    
Y3 = bulk density (g/cc) 
Y4 = microparticle yield (%) 
   
 
 
Table 2. Matrix of 3
2
 full factorial design.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exp. No Total solid content (X1) Feed flow rate (X2) 
1 -1 0 
2 0 0 
3 0 1 
4 -1 1 
5 1 1 
6 1 -1 
7 0 -1 
8 1 0 
9 -1 -1 
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Table 3. Characteristics of DFS/EC spray dried microparticles using a 2-fluid (2-F) 
or 3-fluid (3-F) nozzle at a feed concentration of 5%w/v.  
Nozzle 
used 
 FFR 
(mL/min) 
TOutlet 
(
o
C) 
D10% 
(µm) 
D50% 
 (µm) 
D90% 
 (µm) 
Yield 
(%) 
Inner 3-F 2 43 5.8±0.1 14.6±0.4 33.0±2.9 47.2 
Inner 3-F 4 52 5.6±0.2 13.5±0.7 30.4±3.0 35.9 
Inner 3-F 8 50 5.0±0.0 13.0±0.1 65.7±7.9 35.0 
Outer 3-F 2 53 6.2±0.2 14.2±0.2 31.4±1.8 47.4 
Outer 3-F 4 50 3.8±0.1 8.3±0.0 19.7±1.5 32.0 
Outer 3-F 8 39 3.4±0.0 6.9±0.0 15.0±0.6 36.8 
2-F  2 55 2.4±0.0 7.0±0.1 18.8±1.6 74.4 
2-F 4 53 2.1±0.0 5.3±0.1 11.6±0.2 73.6 
2-F 8 35 4.6±0.1 9.9±0.2 26.5±3.4 66.2 
3-F 4:8 46 2.5±0.1 8.9±0.2 24.8±0.6 42.7 
3-F 8:4 41 2.5±0.1 7.4±0.1 19.7±1.0 40.2 
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Table 4. Microparticle characteristics prepared by using a 3-F nozzle and 2-F 
nozzle.  
Exp 
no 
X1 
(%) 
X2
**
(mL/min) To 
(
o
C) 
D50% 
(µm)  
D90% 
(µm) 
SPAN  Yield 
(%)  
Density  
(g/cc) 
9 2.5 2:2
 
52 7.04±0.19 15.60±0.40 1.84±0.03 67.6 0.164 
1 2.5 4:4
 
45 6.94±0.08 16.12±0.88 1.95±0.11 65.0 0.162 
4 2.5 8:8
 
42 12.87±0.48 29.74±1.80 1.88±0.01 16.6 0.114 
7 5 2:2
 
51 7.07±0.23 16.14±0.07 1.91±0.08 69.2 0.183 
2 5 4:4
 
45 7.39±0.12 17.52±1.13 1.99±0.18 57.8 0.166 
3 5 8:8
 
43 13.32±0.87 32.36±2.83 5.32±3.29 33.9 0.173 
6 10 2:2
 
53 9.37±0.24 25.24±1.62 1.79±0.13 40.7 0.201 
8 10 4:4
 
45 7.23±0.48 36.27±14.2 4.62±1.59 37.5 0.201 
5 10 8:8
 
45 11.31±0.17 46.57±3.04 4.64±0.19 20.5 0.182 
- 2.5
 
8
* 
54 6.75±0.23 15.75±0.39 2.04±0.03 91.2 0.223 
- 5
 
8
* 
35 9.86±0.23 26.52±3.37 2.22±0.29 66.2 0.175 
- 10
 
8
* 
48 12.52±0.54 40.48±4.98 2.87±0.27 29.0 0.173 
*
 FFR through 2-F nozzle, 
**
 FFR through the inner nozzle : FFR through the outer nozzle of the 3-F nozzle  
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Table 5a. Theoretical (predicted) values and the observed (actual) values observed 
for responses Y1 (microparticle size, D50%) and Y2 (microparticle size D90%). 
 
Table 5b. Theoretical (predicted) values and the observed (actual) values observed 
for responses, Y3 (bulk density) and Y4 (microparticle yield). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Y1 (Microparticle size D50% (μm)) Y2 (Microparticle size D90% (μm)) 
 Actual 
Value 
Predicted 
Value 
Residual Actual 
Value 
Predicted 
Value 
Residual 
1 7.04 6.80 0.24 15.60 11.12 4.48 
2 9.37 7.71 -0.64 16.14 16.57 -0.43 
3 7.07 8.96 0.41 25.24 27.45 -2.21 
4 6.94 6.76 0.18 16.12 16.97 -0.85 
5 7.39 7.23 0.16 17.52 22.41 -4.89 
6 7.23 7.57 -0.34 36.27 33.29 2.98 
7 12.87 13.28 -0.41 29.74 28.66 1.08 
8 13.32 12.84 0.48 32.36 34.10 -1.74 
9 11.31 11.37 -0.065 46.57 44.99 1.58 
 Y3 (Bulk density (g/cc)) Y4 (Yield (%)) 
 Actual 
Value 
Predicted 
Value 
Residual Actual 
Value 
Predicted 
Value 
Residual 
1 0.16 0.16 7.8 x 10
-4
 67.62 70.18 -2.56 
2 0.18 0.18 3.7 x 10
-3
 69.21 63.89 5.32 
3 0.20 0.21 -8.0 x 10
-3
 40.73 51.29 -10.56 
4 0.16 0.15 7.8 10
-3
 65.02 57.92 7.10 
5 0.17 0.17 -3.8 x 10
-3
 57.80 51.62 6.18 
6 0.20 0.20 1.2x10
-3
 37.45 39.03 -1.58 
7 0.11 0.14 -0.023 16.64 33.40 -16.76 
8 0.17 0.15 0.021 33.94 27.10 6.84 
9 0.18 0.18 -3.2x10
-4
 20.53 14.51 6.02 
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Figure 1 Diagrammatic representation of spraying and droplet/ MP formation from 
(a) a novel 3-F nozzle and (b) conventional 2-F nozzle   
 
Figure 2 Internal morphology of MPs prepared by spray drying (a) EC solution 
through the outer and DFS solution through the inner core of the 3-F nozzle, (b) DFS and 
EC solution through the 2-F nozzle and (c) EC solution through the outer core of the 3-F 
nozzle  
 
Figure 3 FTIR spectrum of (A) diclofenac sodium (DFS), (B) physical mixture of 
diclofenac sodium and ethyl cellulose, (C) MP prepared using a 2-F nozzle, (D) MP 
prepared using a 3-F nozzle  
 
Figure 4 Morphology of rhodamine and EC polymer droplets formed through the 
(a) 3-F nozzle and (b) 2-F nozzle  
 
Figure 5 Response surface plot showing the effect of X1 (total solid content) and X2 
(feed flow rate) on microparticle characteristics (a) Y1 (median size, D50%), (b) Y2 
(size, D90%), (c) Y3 (bulk density) (d) Y4 (microparticle yield). (
*
feed flow rate (FFR) A:A is 
represented as A.A) 
 
Figure 6 Electron micrographs of MPs prepared using the 3-F nozzle at TSC of 5% 
and FFR of (a) 2:2mL/min, (b) 8:8mL/min, at (c) TSC of 10% and FFR of 2:2mL/min 
and (d) 2-F nozzle at TSC of 10% and FFR of 7mL/min.  
 
Figure 7 DSC thermograms of (I) (a) DFS and (b), spray-dried DFS (II) (a) spray dried 
EC, (b) unprocessed EC, and (c) 1:1 EC:DFS physical mix  (III) MPs formulated at FFR 
of 8mL/min from 2-F nozzle at TSC of (a) 2.5 (b) 5 and (c) 10% w/v and from 3-F 
nozzle at TSC of (d) 2.5% (e) 5% and (f)10% w/v (IV) MPs spray dried at TSC of 5% 
w/v using the 2-F nozzle at FFR of (a) 2 (b) 4 (c) 8mL/min, and the 3-F nozzle at FFR of 
(d) 2 (e) 4 and (f) 8mL/min 
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Diagrammatic representation of spraying and droplet/ MP formation from (a) a novel 3-F nozzle and (b) 
conventional 2-F nozzle    
96012x37490mm (1 x 1 DPI)  
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Internal morphology of MPs prepared by spray drying (a) EC solution through the outer and DFS solution 
through the inner core of the 3-F nozzle, (b) DFS and EC solution through the 2-F nozzle and (c) EC solution 
through the outer core of the 3-F nozzle  
108305x39014mm (1 x 1 DPI)  
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FTIR spectrum of (A) diclofenac sodium (DFS), (B) physical mixture of diclofenac sodium and ethyl cellulose, 
(C) MP prepared using a 2-F nozzle, (D) MP prepared using a 3-F nozzle  
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Morphology of rhodamine and EC polymer droplets formed through the (a) 3-F nozzle and (b) 2-F nozzle  
31x11mm (600 x 600 DPI)  
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Fig 5. Response surface plot showing the effect of X1 (total solid content) and X2 (feed flow rate) on 
microparticle characteristics (a) Y1 (median size, D50%), (b) Y2 (size, D90%), (c) Y3 (bulk density) (d) Y4 
(microparticle yield). (*feed flow rate (FFR) A:A is represented as A.A)  
135x103mm (300 x 300 DPI)  
 
 
Page 29 of 31
URL: http://mc.manuscriptcentral.com/eodd  Email: anneke.prins@informa.com
Expert Opinion on Drug Delivery
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
  
 
 
Electron micrographs of MPs prepared using the 3-F nozzle at TSC of 5% and FFR of (a) 2:2mL/min, (b) 
8:8mL/min, at (c) TSC of 10% and FFR of 2:2mL/min and (d) 2-F nozzle at TSC of 10% and FFR of 
7mL/min.  
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DSC thermograms of (I) (a) DFS and (b), spray-dried DFS (II) (a) spray dried EC, (b) unprocessed EC, and 
(c) 1:1 EC:DFS physical mix  (III) MPs formulated at FFR of 8mL/min from 2-F nozzle at TSC of (a) 2.5 (b) 5 
and (c) 10% w/v and from 3-F nozzle at TSC of (d) 2.5% (e) 5% and (f)10% w/v (IV) MPs spray dried at 
TSC of 5% w/v using the 2-F nozzle at FFR of (a) 2 (b) 4 (c) 8mL/min, and the 3-F nozzle at FFR of (d) 2 (e) 
4 and (f) 8mL/min  
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